+948.4%
MRNA vs NOC
+136.1%
+812.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | NOC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.5% | -0.7% | -2.2% |
| 7D | -12.7% | -2.9% | -9.8% | -12.8% |
| 30D | -20.7% | -0.9% | -19.7% | -20.7% |
| 3M | +46.3% | -4.8% | +51.1% | +46.2% |
| 6M | +305.2% | -2.4% | +307.6% | +304.4% |
| YTD | +561.2% | -5.2% | +566.4% | +561.3% |
| 1Y | +772.1% | -4.3% | +776.4% | +772.4% |
| 3Y | +147.0% | +20.6% | +126.4% | +150.4% |
| 5Y | -26.1% | +64.1% | -90.2% | -22.9% |
| All | +948.4% | +136.1% | +812.3% | +747.6% |
Cumulative growth
Daily Returns
Daily percentage return beside NOC.
Daily Out/Under-Performance
Portfolio return minus NOC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NOC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded NOC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling